(PhysOrg.com) -- Biomaterial scientists in Manchester believe they have found a new way of isolating the ‘ingredients’ needed for potential stem cell treatments for nerve damage and heart disease.
And the technique could also be used in the future to improve the efficiency of bone marrow transplants.
Dr Catherine Merry and Dr Rebecca Baldwin from The School of Materials – working with colleagues from the Paterson Institute for Cancer Research and Nijmegen University in the Netherlands – have developed antibodies that can recognise different patterns within the natural sugars that coat cells in the body.
Writing in the journal Stem Cells, the Manchester scientists report how the technique allows cells to be clearly identified depending on whether the antibodies bind themselves to the cells or not.
Using this method, they can efficiently isolate blood stem cells generated from embryonic stem cells, which then have the potential to be used in the treatment of people with heart and blood cell problems.
The researchers report how the sugars displayed on the surface of a small population of blood stem cells allow them to be distinguished from similar cells which lack blood forming ability.
They believe these sugars may also allow these cells to respond better to the signals which instruct them to become mature blood cell types.
Dr Baldwin, who conducted the research, said: “We were surprised to find that populations of cells which we had previously thought to be all the same were actually mixtures of cell types with differences in their cell surface sugars.
“By using the sugar tags to pull apart this jumble of cells, we can potentially improve the efficiency with which we can make blood cells from embryonic stem cells. Usually we would need to genetically manipulate the DNA in the cells to allow us to tag them in this way.
“We believe our research suggests how sugars can be used to help embryonic stem cells grow in the lab – and also how they can be instructed to become cell types which could be of use in human therapies. These sugars are on the surface of almost all cells and we are looking to see if the same ‘trick’ can be used to make nerve cells.
“Our technique could also be used to improve the efficiency of bone marrow transplantation. After radiotherapy, it could be used to distinguish cells capable of rapidly producing blood cells.
“Although the prospect of creating cells from embryonic stem cells for use in human therapies is still a considerable time away, research such as ours helps move towards this goal.”
All cells that make up the tissues of the body – such as skin, liver, brain and blood – are surrounded by a layer of sugars that coat the cells. These sugars help the cells to know what type of cell they are and to respond to the other cells which surround them and the chemical messages that pass between them.
Provided by University of Manchester
Related stories:
Scientists call up stem cell troops to repair the body using new drug combinations
Scientists have tricked bone marrow into releasing extra adult stem cells into the bloodstream, a technique that they hope could one day be used to repair heart damage or mend a broken bone, in a new study published today in the journal
Cell Stem Cell.
Gene abnormality found to predict childhood leukemia relapse
Scientists have identified mutations in a gene that predict a high likelihood of relapse in children with acute lymphoblastic leukemia (ALL). Although the researchers caution that further research is needed to determine how changes in the gene, called IKZF1 or IKAROS, lead to leukemia relapse, the findings are likely to provide the basis for future diagnostic tests to assess the risk of treatment failure. By using a molecular test to identify this genetic marker in ALL patients, physicians should be better able to assign patients to appropriate therapies.
Embryonic Heart Cells Thrive Only in an Environment That's Just Right
(PhysOrg.com) -- Cellular engineers at the University of Pennsylvania have determined that cardiomyocytes, the specialized cells that form the heart muscle, thrive when cultured in an environment that mimics their own elastic nature but falter, weaken or die when “grown” on stiffer or softer materials.
Converting adult somatic cells to pluripotent stem cells using a single virus
A Boston University School of Medicine-led research team has discovered a more efficient way to create induced Pluripotent Stem (iPS) cells, derived from mouse fibroblasts, by using a single virus vector instead of multiple viruses in the reprogramming process. The result is a powerful laboratory tool and a significant step toward the application of embryonic stem cell-like cells for clinical purposes such as the regeneration of organs damaged by inherited or degenerative diseases, including emphysema, diabetes, inflammatory bowel disease, and Alzheimer's Disease.
'Scrawny' gene keeps stem cells healthy
(PhysOrg.com) -- Stem cells are the body's primal cells, retaining the youthful ability to develop into more specialized types of cells over many cycles of cell division. How do they do it? Scientists at the Carnegie Institution have identified a gene, named scrawny, that appears to be a key factor in keeping a variety of stem cells in their undifferentiated state. Understanding how stem cells maintain their potency has implications both for our knowledge of basic biology and also for medical applications. The results will be published in the January 9, 2009 print edition of
Science.
Testes stem cell can change into other body tissues, study shows
Scientists at the Stanford University School of Medicine and at UC-San Francisco have succeeded in isolating stem cells from human testes. The cells bear a striking resemblance to embryonic stem cells — they can differentiate into each of the three main types of tissues of the body — but the researchers caution against viewing them as one and the same.
Scientists can now differentiate between healthy cells and cancer cells
One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells.
Researchers develop novel glioblastoma mouse model
Researchers at the Salk Institute for Biological Studies have developed a versatile mouse model of glioblastoma—the most common and deadly brain cancer in humans—that closely resembles the development and progression of human brain tumors that arise naturally.